Close

People Battling Illnesses, Injuries Discuss Personal Experiences At BIO 2000

WASHINGTON, DC (March 22, 2000) People benefiting from innovative biotechnology treatments against such diseases as rheumatoid arthritis, multiple sclerosis and Gaucher disease will discuss their...

BIO 2000 Speakers Discuss Human Genome Project, Agricultural Biotech In Developing Nations

WASHINGTON, D.C. (March 17, 2000) Featured speakers at BIO 2000's lunch Wednesday, March 29, will discuss a variety of topics, including the risks and benefits of agricultural biotechnology in...

Backgrounder On Patenting Gene-Based Inventions

...

BIO 2000 Attracts Record International Contingent

Washington, D.C., (March 14, 2000) -- BIO 2000 in Boston, March 26-30, will include the largest international contingent ever assembled for the annual conference of the Biotechnology Industry...

BIO Responds To Clinton, Blair Statement On Gene-Based Health-Care Research

WASHINGTON, DC (March 14, 2000) The Biotechnology Industry Organization (BIO) issued the following response to the statement made today by President Bill Clinton and British Prime Minister Tony...

Testimony of Michael J. Werner, Esq.

On behalf of the Biotechnology Industry Organization (BIO), regarding the Proposal That Calls For A Moratorium on Some Human Gene Therapy Protocols before the NIH Recombinant DNA Advisory Committee.

BIO Testifies In Support Of Gene Therapy Trials

WASHINGTON, D.C. (March 10, 2000) The Biotechnology Industry Organization (BIO) applauded the National Institutes of Health Recombinant DNA Advisory Committee (RAC) for its decision today to...

Maine Price Controls Will Stifle Biotech Innovation

WASHINGTON, D.C. (March 8, 2000) Nancy Myers, health care policy and reimbursement counsel of the Biotechnology Industry Organization (BIO), issued the following statement concerning legislation...

BIO 2000 Science Presentations Feature Latest Research Breakthroughs

WASHINGTON, D.C. (March 7, 2000) BIO 2000 in Boston, March 26-30, will feature four days of scientific presentations examining the latest research on a variety of life-threatening diseases and...

BIO Response to National Organic Standards

(Dr. Val Giddings, vice president for food and agriculture for BIO, today issued the following statement regarding USDA’s proposed new national organic standards):

WASHINGTON, D.C. ...